Company pivots from biotech to copper exploration in Morocco, Brandon Beylo notes

Company pivots from biotech to copper exploration in Morocco, Brandon Beylo notes
Micro cap firm pivots to copper exploration

Brandon Beylo reports on an unusual occurrence in the micro cap sector, where a company has suspended all biotech research and development operations to transform into a copper explorer in Morocco.

This dramatic shift in business strategy highlights the unpredictable nature of some micro cap firms, as described by Beylo.

Beylo has recently flagged changing trends in the sector, such as the acquisition of Crinetics Pharma by Vertex Pharma at a 100 percent premium. He also noted the potential for further declines in gold, suggesting it could drop to $3,800 per ounce before recovering. These observations reflect shifting conditions across both biotech and commodities.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.